The diagnosis of infection by a hantavirus uses serologic techniques. The patient's blood is drawn, and the ELISA (enzyme-linked immunosorbent assay) is done in a laboratory to identify the presence of specific immune substances (antibodies)—substances which an individual's body would only produce in response to the hantavirus.
It is very difficult to demonstrate the actual virus in human tissue, or to grow cultures of the virus within the laboratory, so the majority of diagnostic tests use indirect means to demonstrate the presence of the virus.
Treatment of hantavirus infections is primarily supportive, because there are no agents available to kill the viruses and interrupt the infection. Broad-spectrum antibiotics are given until the diagnosis is confirmed. Supportive care consists of providing treatment in response to the patient's symptoms. Because both HFRS and HPS progress so rapidly, patients must be closely monitored, so that treatment may be started at the first sign of a particular problem. Low blood pressure is treated with medications. Blood transfusions are given for both hemorrhage and shock states. Hemodialysis is used in kidney failure. (Hemodialysis involves mechanically cleansing the blood outside of the body, to replace the kidney's normal function of removing various toxins form the blood.) Rapid respiratory assistance is critical, often requiring intubation.
The anti-viral agent ribavirin has been approved for use in early treatment of hantavirus infections.
The diseases caused by hantaviruses are extraordinarily lethal. About 6–15% of people who contract HFRS have died. Almost half of all people who contract HPS will die. It is essential that people living in areas where the hantaviruses exist seek quick medical treatment, should they begin to develop an illness that might be due to a hantavirus.
There are no immunizations currently available against any of the hantaviruses. The only forms of prevention involve rodent control within the community and within individual households. The following is a list of preventative measures:
Harper, David R. and Andrea S. Meyer. Of Mice, Men, and Microbes: Hantavirus. San Diego: Academic Press, 1999.
Stoffman, Phyllis. The Family Guide to Preventing and Treating 100 Infectious Diseases. New York: John Wiley and Sons, Inc., 1995.
Jones, Amy. "Setting a Trap for Hantavirus." Nursing (September 2000): 20.
Monroe, Martha C., Sergey P. Morzunov, Angela M. Johnson, Michael De. Bowen, et al. "Genetic Diversity and Distribution of Peromyscus-Borne Hantaviruses in North America." Nursing (January-February 1999): 75-86.
Naughton, Laurie. "Hantavirus Infection in the United States: Are We Prepared?." Physician Assistant (May 2000): 33.
Rhodes III, Luther V., Cinnia Huang, Angela J. Sanchez, Stuart T. Nichol, et al. "Hantavirus Pulmonary Syndrome Associated with Monongahela Virus, Pennsylvania." Emerging Infectious Diseases (November 2000): 616.
Van Bevern, Pamela A. "Hantavirus Pulmonary Syndrome." Clinician Reviews (July 2000): 108.
Centers for Disease Control and Prevention. (404) 332-4559. <http://www.cdc.gov/travel/travel.html>.
Janie F. Franz
Hemodialysis—A method of mechanically cleansing the blood outside of the body, in order to remove various substances which would normally be cleared by the kidneys. Hemodialysis is used when an individual is in relative, or complete, kidney failure.
Hemorrhagic—A condition resulting in massive, difficult-to-control bleeding.
Petechiae—Pinpoint size red spots caused by hemorrhaging under the skin.
Platelets—Circulating blood cells which are crucial to the mechanism of clotting.
Prodrome—Early symptoms or warning signs
Pulmonary—Referring to the lungs.
Renal—Referring to the kidneys.
Shock—Shock is a state in which blood circulation is insufficient to deliver adequate oxygen to vital organs.
|
|
Author Info: Janie F. Franz, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Medicine, 2002 |